Switzerland startup funding in H2 2020
European tech funding raised by Switzerland startups during H2 2020.
In H2 2020, 107 startups in Switzerland closed 111 funding rounds and raised €1.1B in equity funding (excluding debt and grants), up 62.5% versus H2 2019. Debt rounds added €17M. Healthtech was the most active sector, and Swisscom Ventures was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.1B
+62.5% vs H2 2019 · excl. debt & grants · +€17M debt
Funding rounds
111
+73.4% vs H2 2019
Companies
107
Top sector
Healthtech
Rank in Europe
#7
3.6% of European funding
Debt financing
€17M
1.5% of total
Top-10 round share
54.0%
of disclosed capital
Funding by month
€ raised vs rounds, by monthSwitzerland — funding by month, H2 2020 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €99M | 18 |
| Aug | €51M | 15 |
| Sep | €276M | 23 |
| Oct | €319M | 17 |
| Nov | €226M | 19 |
| Dec | €181M | 19 |
Top sectors
by € raisedSwitzerland — top sectors by capital, H2 2020 — interactive chart.
Data table
| Switzerland — top sectors by capital, H2 2020 | |
|---|---|
| Healthtech | €582M |
| Cleantech | €178M |
| Software | €178M |
| Fintech | €109M |
| Semiconductors | €93M |
| Robotics | €34M |
| AI | €29M |
| Cybersecurity | €27M |
Stage mix
by € raisedSwitzerland — stage mix, H2 2020 — interactive chart.
Data table
| Switzerland — stage mix, H2 2020 | |
|---|---|
| Other | €488M |
| Series A | €235M |
| Series B | €147M |
| Series D+ | €110M |
| Series C | €93M |
| Seed | €50M |
| Debt | €17M |
| ICO | €12M |
| Pre-Seed | €1.7M |
| Grant | €522k |
Top deals
largest disclosed rounds in H2 2020| Company | Stage | Date | Amount |
|---|---|---|---|
| Sophia Genetics | Series D+ | Oct 2020 | €94M |
| Vectivbio | Other | Oct 2020 | €94M |
| Climeworks | Other | Sep 2020 | €93M |
| Kandou | Other | Nov 2020 | €78M |
| Pharvaris | Series C | Nov 2020 | €67M |
| Trafigura | Other | Dec 2020 | €52M |
| Spineart | Other | Oct 2020 | €46M |
| Carvolution | Series B | Sep 2020 | €46M |
| Vectivbio | Series A | Sep 2020 | €29M |
| T3 Pharmaceuticals | Other | Jul 2020 | €23M |
| NBE-Therapeutics | Other | Sep 2020 | €21M |
| Numab | Series B | Sep 2020 | €20M |
| Bitcoin Suisse | Series A | Nov 2020 | €20M |
| NBE-Therapeutics | Series C | Oct 2020 | €19M |
| H55 | Other | Dec 2020 | €19M |
Top investors
most active in H2 2020, by deal count- Swisscom Ventures5 deals
- Alpana Ventures4 deals
- Spicehaus Partners2 deals
- StartAngels Network2 deals
- Venture Kick2 deals
- Giesecke+Devrient2 deals
- SIX FinTech Ventures2 deals
- Wingman Ventures2 deals
- 4FO Ventures2 deals
- Calvin Ayre1 deals